MLYS Stock-Based Compensation

Mineralys Therapeutics Inc · Stock-Based Compensation

MLYS logo

MLYS Stock-Based Compensation

Latest reported$7.36M
MLYS Quarterly Stock-Based Comp ($16.00K → $7.36M)
High-resolution chart · PNG

MLYS stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Mineralys Therapeutics Inc Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
7,355,000
6,548,000
5,285,000
5,841,000
4,553,000
3,645,000
3,134,000
3,139,000
2,872
2,191,000
1,457,000
1,578,000
1,276,000
749,000
218,000
192,000
26,000
19,000
16,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.